How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 201–300 of 1,000
Balasubaramaniam, V., & Pouwels, S. (2023) · Medicina · doi:10.3390/medicina59050985 · Cited by 62
Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass
Park, J. Y., & Kim, Y. J. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1823-3 · Cited by 56
“Remission of diabetes was defined according to ADA criteria [14].”
MethodRogers, C. A., Welbourn, R., Byrne, J., Donovan, J. L., Reeves, B. C., Wordsworth, S., Andrews, R., Thompson, J. L., Roderick, P., Mahon, D., et al. (2014) · Trials · doi:10.1186/1745-6215-15-53 · Cited by 49
Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery
Souteiro, P., Belo, S., Neves, J. S., Magalhães, D. M. D. S., Silva, R. B., Oliveira, S. C., Costa, M. M., Saavedra, A., Oliveira, J., Cunha, F. M., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2300-3 · Cited by 57
Lager, C. J., Esfandiari, N. H., Luo, Y., Subauste, A. R., Kraftson, A. T., Brown, M. B., Varban, O. A., Meral, R., Cassidy, R. B., Nay, C. K., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3346-1 · Cited by 53
Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes
Merrill, J. D., Soliman, D., Kumar, N., Lim, S., Shariff, A. I., & Yancy, W. S. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0070 · Cited by 49
Remission of Recently Diagnosed Type 2 Diabetes Mellitus With Weight Loss and Exercise
Ades, P. A., Savage, P. D., Marney, A. M., Harvey, J., & Evans, K. A. (2015) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000106 · Cited by 50
Lee, W., Ahn, S. H., Lee, J. H., Park, D. J., Lee, H., Kim, H., & Yang, H.-K. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0580-1 · Cited by 53
Seki, Y., Kasama, K., Haruta, H., Watanabe, A., Yokoyama, R., Porciuncula, J. P., Umezawa, A., & Kurokawa, Y. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2372-0 · Cited by 52
“Diabetes remission was defined as HbA1c <6%without use of any diabetes medications [6].”
Atkin, S. L., Ramachandran, V., Yousri, N. A., Benurwar, M., Simper, S. C., McKinlay, R. D., Adams, T. D., Najafi-Shoushtari, S. H., & Hunt, S. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00773 · Cited by 52
Single-Anastomosis Sleeve Ileal (SASI) Bypass: Hopes and Concerns after a Two-Year Follow-up
Khalaf, M., & Hamed, H. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04945-y · Cited by 54
Bariatric surgery and diabetes remission: Who would have thought it?
Singh, A., Singh, R., & Kota, S. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.163113 · Cited by 48
Nguyen, K. T., & Körner, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0481-5 · Cited by 51
Jiménez, A., Ceriello, A., Casamitjana, R., Flores, L., Viaplana-Masclans, J., & Vidal, J. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000586 · Cited by 51
Self-citationBetzel, B., Homan, J., Aarts, E. O., Janssen, I. M. C., de Boer, H., Wahab, P. J., Groenen, M. J. M., & Berends, F. J. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-5299-6 · Cited by 49
Surgery or Medical Therapy for Obese Patients with Type 2 Diabetes?
Zimmet, P., & Alberti, K. G. M. M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1202443 · Cited by 48
DePaula, A. L., Stival, A. R., DePaula, C. C. L., Halpern, A., & Vencio, S. A. C. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1807-0 · Cited by 51
Impact of Different Criteria on Type 2 Diabetes Remission Rate After Bariatric Surgery
On Behalf of the Obemar Group, Mas-Lorenzo, A., Benaiges, D., Roux, J. A. F., Pedro-Botet, J., Ramón, J. M., Parri, A., Villatoro, M., Chillarón, J. J., Pera, M., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1282-2 · Cited by 51
“Complete T2DM remission was defined as glycemia below diabetic range in the absence of pharmacologic therapy for at least 1 year [10].”
BackgroundResultEl-Matbouly, M. A., Khidir, N., Touny, H. A., Ansari, W. E., Al-Kuwari, M., & Bashah, M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2884-2 · Cited by 48
“6 mmol/ L)] for a duration of at least 1 year in the absence of active pharmacological therapy or ongoing procedures [21].”
BackgroundMethodValidating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy
Shen, S., Wang, W., Tam, K., Chen, H., Lin, Y., Wang, S.-Y., Huang, M., & Su, Y. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3510-7 · Cited by 49
Dicker, D., Golan, R., Aron‐Wisnewsky, J., Zucker, J., Sokolovska, N., Comaneshter, D. S., Yahalom, R., Vinker, S., Clément, K., & Rudich, A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3583-3 · Cited by 51
Defining remission of type 2 diabetes in research studies: A systematic scoping review
Captieux, M., Prigge, R., Wild, S., & Guthrie, B. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003396 · Cited by 43
“” It broadly defines remission as “achieving glycaemia below the diabetic range in the absence of active pharmacologic or surgical therapy” [10] (p.”
BackgroundMethodInfluentialShamanna, P., Joshi, S., Shah, L., Dharmalingam, M., Saboo, B., Mohammed, J., Mohamed, M., Poon, T., Kleinman, N. L., Thajudeen, M., et al. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00134-7 · Cited by 53
Ramos-Levi, A. M., Matía‐Martín, P., Cabrerizo, L., Barabash, A., Sánchez-Pernaute, A., Calle‐Pascual, A. L., Torres, A. J., & Rubio, M. Á. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12127 · Cited by 49
Doğan, K., Betzel, B., Homan, J., Aarts, E. O., Ploeger, N., de Boer, H., Aufenacker, T. J., van Laarhoven, C. J. H. M., Janssen, I. M. C., & Berends, F. J. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1310-2 · Cited by 52
“Primary endpoint was remission of T2DM according to the definition of 2009 consensus statement [18].”
Almalki, O. M., Lee, W., Chong, K., Ser, K., Lee, Y.-C., & Chen, S. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.12.022 · Cited by 51
Min, T., Prior, S. L., Dunseath, G. J., Churm, R., Barry, J. D., & Stephens, J. W. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04377-3 · Cited by 46
Alamo, M., Sepúlveda, M., Gellona, J., Herrera, M., Astorga, C., & Manterola, C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0652-x · Cited by 46
Remission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Juray, S., Axen, K. V., & Trasino, S. E. (2021) · Nutrients · doi:10.3390/nu13062086 · Cited by 45
Gregg, E. W., Boyle, J. P., Thompson, T. J., Barker, L. E., Albright, A. L., & Williamson, D. F. (2013) · Population Health Metrics · doi:10.1186/1478-7954-11-18 · Cited by 47
Neff, K., Baud, G., Raverdy, V., Caiazzo, R. J., Verkindt, H., Noël, C., le Roux, C. W., & Pattou, F. N. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2333-7 · Cited by 48
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
“As T2D improves rapidly and more significantly following BS than with intensive medical therapy [44], a new clinical concept has emerged: diabetes remission (DR), which is defined as the normalization of glycemic parameters in the absence of glucose-lowering agents 1 year post-BS [45].”
BackgroundInfluentialMottalib, A., Sakr, M., Shehabeldin, M., & Hamdy, O. (2015) · Journal of Diabetes Research · doi:10.1155/2015/468704 · Cited by 44
Umphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44
“The criteria used in our study are, therefore, almost consistent with partial remission according to the Consensus Statement (Buse et al., 2009).”
BackgroundMethodInfluentialDePaula, A. L., Stival, A. R., Halpern, A., & Vencio, S. A. C. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0232-x · Cited by 47
Huang, C., Tai, C., Chang, P., Malapan, K., Tsai, C., & Yolsuriyanwong, K. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2118-z · Cited by 44
Souto, K. P., Meinhardt, N. G., Ramos, M. J., Kulczynski, J. M. U., Stein, A. T., & Damin, D. C. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.09.527 · Cited by 59
Long-term Effects of Laparoscopic Sleeve Gastrectomy: What Are the Results Beyond 10 Years?
Kraljević, M., Cordasco, V., Schneider, R., Peters, T. T. A., Slawik, M., Wölnerhanssen, B. K., & Peterli, R. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05437-3 · Cited by 47
Zhao, L., Ni, Y., Yu, H., Zhang, P., Zhao, A., Bao, Y., Liu, J., Chen, T., Xie, G., Panee, J., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600927r · Cited by 48
“0 mM for 1 yr or more without active pharmacological intervention (21).”
BackgroundCao, Y., Näslund, I., Näslund, E. B., Ottosson, J., Montgomery, S., & Stenberg, E. (2021) · JMIR Medical Informatics · doi:10.2196/25612 · Cited by 48
“0%) in accordance with the definitions of the American Diabetes Association [21].”
ResultInfluentialSurgery in the treatment of type 2 diabetes mellitus
Maleckas, A., Venclauskas, L., Wallenius, V., Lönroth, H., & Fändriks, L. (2015) · Scandinavian Journal of Surgery · doi:10.1177/1457496914561140 · Cited by 48
Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes
Aung, L., Lee, W.-J., Chen, S. C., Ser, K.-H., Wu, C.-C., Chong, K., Lee, Y.-C., & Chen, J.-C. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.1130 · Cited by 37
Metabolic surgery improves renal injury independent of weight loss: a meta-analysis
Scheurlen, K. M., Probst, P., Kopf, S., Nawroth, P. P., Billeter, A. T., & Müller-Stich, B. P. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.03.013 · Cited by 44
Metabolic and Bariatric Surgery for Obesity
Vidal, J., Corcelles, R., Jiménez, A., Flores, L., & Lacy, A. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.051 · Cited by 45
Network meta‐analysis of the relative efficacy of bariatric surgeries for diabetes remission
Kodama, S., Fujihara, K., Horikawa, C., Harada, M., Ishiguro, H., Kaneko, M., Furukawa, K., Matsubayashi, Y., Matsunaga, S., Shimano, H., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12751 · Cited by 42
Ahuja, A., Tantia, O., Chaudhuri, T., Khanna, S., Seetharamaiah, S., Majumdar, K., & Goyal, G. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3136-9 · Cited by 42
Purnell, J. Q., Johnson, G., Wahed, A. S., Man, C. D., Piccinini, F., Cobelli, C., Prigeon, R. L., Goodpaster, B. H., Kelley, D. E., Staten, M. A., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4553-y · Cited by 43
Lupoli, R., Lembo, E., Ciciola, P., Schiavo, L., Pilone, V., & Capaldo, B. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.029 · Cited by 41
Kaska, Ł., Kobiela, J., Proczko, M., Stefaniak, T., & Śledziński, Z. (2014) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2014.40383 · Cited by 41
Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy
Capoccia, D., Coccia, F., Guarisco, G., Testa, M., Rendina, R., Abbatini, F., Silecchia, G., & Leonetti, F. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3153-8 · Cited by 40
“The proportion of patients meeting the ADA target of A1c less than 7% at long-term follow-up was significantly greater than at the baseline (52.4 vs 38.4%, p 0.001).”
InfluentialMiras, A. D., Kamocka, A., Pérez‐Pevida, B., Purkayastha, S., Moorthy, K., Patel, A. G., Chahal, H., Frost, G. S., Bassett, P., Castagneto‐Gissey, L., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0762 · Cited by 43
“Diabetes remission was defined based on a variation of the American Diabetes Association criteria (27) as an HbA1c <48 mmol/mol and fasting glucose <5.”
MethodSelf-citationAlmuhanna, M., Soong, T., Lee, W., Chen, J., Wu, C., & Lee, Y.-C. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.01.010 · Cited by 41
Shah, K., Nergård, B.-J., Frazier, K. S., Leifsson, B. G., Aghajani, E., & Gíslason, H. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.017 · Cited by 39
“According to the consensus statement from 2009 [13], remission of T2D is defined as follows: 165 166 167 168 169 170 171 172 173 Complete remission: FPG o5.”
MacKay, D., Chan, C. B., Dasgupta, K., Dominy, C., Gagner, M., Jin, S., Kim, J., Little, J. P., MacDonald, B., McInnes, N., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.10.004 · Cited by 46
“5% without antihyperglycemic medications (59).”
Heneghan, H., Huang, H., Kashyap, S. R., Gornik, H. L., McCullough, A. J., Schauer, P. R., Brethauer, S. A., Kirwan, J. P., & Kasumov, T. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.018 · Cited by 41
Hirsch, F. F., Pareja, J. C., Geloneze, S. R., Chaim, É. A., Cazzo, E., & Geloneze, B. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0589-0 · Cited by 38
“Type 2 diabetes was considered to be in remission if the A1C level was in the normal range (below 6%) and the fasting glucose level was <100 mg/dL for at least 1 year in the absence of active pharmacological therapy [3].”
BackgroundAdes, P. A. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.03.014 · Cited by 38
Reusch, C. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00007-9 · Cited by 50
Hernández-Montoliu, L., Rodríguez‐Peña, M., Puig, R., Astiarraga, B., Guerrero‐Pérez, F., Virgili, N. M., López‐Urdiales, R., Osorio, J., Monseny, R., Lazzara, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1181744 · Cited by 44
Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health
Miras, A. D., & le Roux, C. W. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70158-x · Cited by 40
Long-term impact of bariatric surgery in diabetic nephropathy
Young, L. H., Hanipah, Z. N., Brethauer, S. A., Schauer, P. R., & Aminian, A. (2018) · Surgical Endoscopy · doi:10.1007/s00464-018-6458-8 · Cited by 37
Schulte, F., Asbeutah, A. A., Benotti, P. N., Wood, G. C., Still, C. D., Bistrian, B. R., Hardt, M., & Welty, F. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-75353-6 · Cited by 40
Peng, D., Liu, X., Cheng, Y.-X., Tao, W. Y., & Cheng, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.694997 · Cited by 37
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study
Moriconi, D., Manca, M. L., Anselmino, M., Rebelos, E., Bellini, R., Taddei, S., Ferrannini, E., & Nannipieri, M. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101282 · Cited by 40
Analytical Challenges in Diabetes Management: Towards Glycated Albumin Point-of-Care Detection
Rescalli, A., Varoni, E. M., Cellesi, F., & Cerveri, P. (2022) · Biosensors · doi:10.3390/bios12090687 · Cited by 42
“Despite the existence of successful medical strategies to keep the DM condition under control, a definitive, gold standard therapy for treatment is still lacking, and patients remain lifelong at risk of relapse and uncontrolled disease [8].”
BackgroundKwon, Y., Abdemur, A., Menzo, E. L., Park, S. S., Szomstein, S., & Rosenthal, R. J. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.09.013 · Cited by 39
Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass?
Lee, W., Chong, K., Aung, L., Chen, S., Ser, K., & Lee, Y. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3690-z · Cited by 41
“0 % without anti-diabetes medication for 1 year and prolong remission as diabetes remission more than 5 years [19].”
BackgroundWood, G. C., Horwitz, D., Still, C. D., Mirshahi, T., Benotti, P. N., Parikh, M., & Hirsch, A. G. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2799-y · Cited by 37
Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus
Seki, Y., Kasama, K., Umezawa, A., & Kurokawa, Y. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2057-8 · Cited by 36
Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes
Roesch, S. L., Styer, A. M., Wood, G. C., Kosak, Z., Seiler, J. L., Benotti, P. N., Petrick, A. T., Gabrielsen, J. D., Strodel, W. E., Gerhard, G. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116928 · Cited by 38
Sarkar, D., Sharma, R., Singh, P., Verma, V., Karkhur, S., Verma, S., Soni, D., & Sharma, B. B. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2020_22 · Cited by 35
“5% are categorized as diabetic as per the American Diabetic Association (ADA).[10]”
BackgroundPetry, T. Z., Fabbrini, E., Otoch, J. P., Carmona, M. A., Caravatto, P. P., Salles, J. E., Sarian, T., Correa, J. L., Schiavon, C. A., Patterson, B. W., et al. (2015) · Obesity · doi:10.1002/oby.21190 · Cited by 32
“Diabetes remission The definition of partial and complete remission of diabetes was based on the recommendations of an expert consensus conference held in June 2009 (13).”
MethodZheng, L., Linarelli, L. E., Brooke, J., Smith, C., Wall, S. S., Greenawald, M. H., Seidel, R. W., Estabrooks, P. A., Almeida, F. A., & Cheng, Z. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5290638 · Cited by 37
de Oliveira, V. L. P., Martins, G. P., Mottin, C. C., Rizzolli, J., & Friedman, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2830-3 · Cited by 39
Guerrero‐Pérez, F., Casajoana, A., Gómez‐Vaquero, C., Virgili, N. M., López‐Urdiales, R., Hernández-Montoliu, L., Pujol-Gebellí, J., Osorio, J., Alves, C., Pérez-Maraver, M., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04127-5 · Cited by 35
Prasad, J., Vogels, E., DOVE, J. T., Wood, C., Petrick, A. T., & Parker, D. M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.019 · Cited by 34
Jassil, F. C., Carnemolla, A., Kingett, H., Doyle, J., Kirk, A., Lewis, N., Montagut, G., Marvasti, P., Boniface, D. R., Brown, A. C., et al. (2023) · Obesity · doi:10.1002/oby.23814 · Cited by 34
Laparoscopic sleeve gastrectomy versus laparoscopic gastric bypass: A retrospective cohort study
Bhandari, M., Reddy, M. K., Kosta, S., Mathur, W., & Fobi, M. A. L. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.05.004 · Cited by 35
Decreased Weight Loss Following Bariatric Surgery in Patients with Type 2 Diabetes
Rebelos, E., Moriconi, D., Honka, M., Anselmino, M., & Nannipieri, M. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06350-z · Cited by 35
Gastrointestinal Surgery for Obesity and Diabetes: Weight Loss and Control of Hyperglycemia
Heneghan, H., Nissen, S. E., & Schauer, P. R. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0285-5 · Cited by 35
Kim, M. K., Kim, W., Kwon, H., Baek, K., Kim, E. K., & Song, K. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12137 · Cited by 35
Besic, V., Shi, H., Stubbs, R. S., & Hayes, M. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119270 · Cited by 35
“6 mmol/l and no continuing treatment one year after surgery) [38].”
BackgroundGulliford, M. C., Charlton, J., Booth, H., Fildes, A., Khan, O. A., Reddy, M., Ashworth, M. J., Littlejohns, P., Prevost, A. T., & Rudisill, C. (2016) · Health Services and Delivery Research · doi:10.3310/hsdr04170 · Cited by 43
“663 Antihypertensive, n (%) 572 (44) 985 (57) 1.”
Parikh, M., Issa, R., Vieira, D., McMacken, M., Saunders, J. K., Ude-Welcome, A., Schubart, U., Ogedegbe, G., & Pachter, L. H. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.04.023 · Cited by 34
Amouyal, C., Buyse, M., Lucas-Martini, L., Hirt, D., Genser, L., Torcivia, A., Bouillot, J., Oppert, J., & Aron‐Wisnewsky, J. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3308-7 · Cited by 35
Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?
Cotillard, A., Poitou, C., Duchâteau-Nguyen, G., Aron‐Wisnewsky, J., Bouillot, J., Schindler, T. H., & Clément, K. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1511-8 · Cited by 34
“7 %) when predicting remission 1 year after surgery according to the ADA partial criteria [16].”
MethodUsinger, L., Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, J. J., & Knop, F. K. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0362-9 · Cited by 38
“The term “resolution” is used inconsistently (although consensus criteria have recently been published [26]) and covers discontinuation of diabetes medications and/or blood glucose levels (HbA1c or FPG or non-fasting PG/blood glucose) within “normal range”—the latter expression often not specified.”
BackgroundSeki, Y., Kasama, K., Yasuda, K., Yokoyama, R., Porciuncula, J. P., & Kurokawa, Y. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3179-y · Cited by 33
“Diagnosis of T2DM was based on the American Diabetes Association’s (ADA) criteria [11].”
MethodCan a Protocol for Glycaemic Control Improve Type 2 Diabetes Outcomes After Gastric Bypass?
Fenske, W. K., Pournaras, D. J., Aasheim, E. T., Miras, A. D., Scopinaro, N., Scholtz, S., & le Roux, C. W. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0543-6 · Cited by 34
“6 mmol/L and HbA1c<6% in the absence of active glucose-lowering pharmacotherapy for 1 year [15].”
BackgroundResultKapeluto, J., Tchernof, A., Masckauchan, D., Biron, S., Marceau, S., Hould, F., Lebel, S., Lescelleur, O., Julien, F., & Biertho, L. D. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.06.052 · Cited by 39
Sjöholm, K., Carlsson, L. M. S., Taube, M., le Roux, C. W., Svensson, P., & Peltonen, M. (2020) · Diabetes Care · doi:10.2337/dc20-0157 · Cited by 33
Type 2 Diabetes Remission 5 Years After Laparoscopic Sleeve Gastrectomy: Multicenter Cohort Study
Mizera, M., Wysocki, M., Bartosiak, K., Franczak, P., Hady, H. R., Kalinowski, P., Myśliwiec, P., Orłowski, M., Paluszkiewicz, R., Piecuch, J., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05088-w · Cited by 35
Captieux, M., Fleetwood, K., Kennon, B., Sattar, N. A., Lindsay, R. S., Guthrie, B., & Wild, S. H. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003828 · Cited by 34
“A widely cited 2009 report by a multidisciplinary expert group was ambiguous as to whether both HbA1c and FPG measures are required to define remission [6], although a more recent position statement advises that remission can be defined in terms of HbA1c or FPG [4].”
BackgroundInfluentialPredictors of type-2 diabetes remission following bariatric surgery after a two-year follow-up
Salman, M. A., Rabiee, A., Salman, A., Elewa, A., Tourky, M. S., Mahmoud, A. A., Moustafa, A., Shaaban, H. E., Ismail, A. A., Noureldin, K., et al. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.12.070 · Cited by 34
Vasdeki, D., Koufakis, T., Tsamos, G., Busetto, L., Zebekakis, P. E., & Kotsa, K. (2022) · Nutrients · doi:10.3390/nu14224801 · Cited by 33
Umemura, A., Sasaki, A., Nitta, H., Otsuka, K., Suto, T., & Wakabayashi, G. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0524 · Cited by 33
Nosso, G., Lupoli, R., Saldalamacchia, G., Griffo, E., Cotugno, M., Costabile, G., Riccardi, G., & Capaldo, B. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.07.004 · Cited by 33
Lewis, K. H., Arterburn, D. E., Zhang, F., Kim, K. C., Wallace, J., Fernandez, A., Ross‐Degnan, D., & Wharam, J. F. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003391 · Cited by 34
Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery
Pessoa, B. M., Browning, M. G., Mazzini, G. S., Wolfe, L. G., Kaplan, A. M., Khoraki, J., & Campos, G. M. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.09.012 · Cited by 32
Wei, Z.-W., Li, J.-L., Wu, Y., Xia, G., Schwarz, R. E., He, Y.-L., & Zhang, C.-H. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2965-6 · Cited by 33
“9 mmol/l)] of at least 1 year’s duration in the absence of active pharmacologic therapy or ongoing procedures [24].”
Background
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.